Sunanda A Ranadive

Title: Sunanda A Ranadive: Innovator in Pediatric Formulations

Introduction

Sunanda A Ranadive is a notable inventor based in East Brunswick, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in developing pediatric formulations. With a total of 3 patents to her name, her work has had a meaningful impact on the medical community.

Latest Patents

One of her latest patents involves a pediatric formulation of gatifloxacin. This invention provides a quinolone antibacterial agent that is adequately taste-masked for use in pediatric formulations. The crystalline co-precipitate of gatifloxacin, combined with stearic acid and palmitic acid in a specific weight ratio, effectively masks the bitter taste of gatifloxacin. This formulation ensures that the taste is masked throughout a full dosage cycle, typically lasting fourteen days. Additionally, gatifloxacin in these crystalline co-precipitates is readily available for absorption from the stomach, enhancing its efficacy.

Career Highlights

Sunanda A Ranadive is associated with Bristol-Myers Squibb Company, where she has been instrumental in advancing pharmaceutical innovations. Her work focuses on improving drug formulations to enhance patient compliance, especially in pediatric care.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Krishnaswamy Srinivas Raghavan and Robert Abramowitz. These collaborations have further enriched her research and development efforts.

Conclusion

Sunanda A Ranadive's contributions to pediatric formulations exemplify her dedication to improving healthcare for children. Her innovative work continues to pave the way for advancements in pharmaceutical science.